Latest

The United States has approved the first "oral weight-loss miracle drug," with Novo Nordisk taking the lead and its stock price soaring, while Eli Lilly is expected to receive approval in March.

The United States has approved the first "oral weight-loss miracle drug," with Novo Nordisk taking the lead and its stock price soaring, while Eli Lilly is expected to receive approval in March.

Before Eli Lilly could react, Novo Nordisk has regained an edge in the competition for the US weight loss drug market. On Monday, December 22, the US Food and Drug Administration (FDA) approved Danish pharmaceutical giant Novo Nordisk’s first oral GLP-1 weight loss drug. This new medication is the
Admin